If the blood test - from California-based biotechnology company Freenome - was approved for market, it would be one of the ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.

A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the ...

About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.

A promising experimental blood test has shown the ability to accurately detect colon cancer with 81% accuracy in patients and ...

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

A simple blood test has shown promising results in accurately detecting colon cancer, a deadly disease that is rising at an ...